isosorbide-5-mononitrate has been researched along with Prostatic Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Çelik, O; Eryıldırım, B; Faydacı, G; Tarhan, F; Tosun, Ç | 1 |
1 trial(s) available for isosorbide-5-mononitrate and Prostatic Hyperplasia
| Article | Year |
|---|---|
Comparison of the efficacy of isosorbide mononitrate and doxazosin in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia: a randomized clinical trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Doxazosin; Drug Administration Schedule; Humans; Isosorbide Dinitrate; Lower Urinary Tract Symptoms; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Urinary Retention | 2014 |